EUVIMEDEUVIMED entdecken
Open Access

NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunity

Zoe K Bedrosian, Elizabeth M Ruark, Neekun Sharma, Rachel B Silverstein, Allison Manning, Lauren Kohlsaat, Mary A Markiewicz iD

The Journal of Immunology · 2025

DOI: 10.1093/jimmun/vkaf030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Zoe K Bedrosian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, KS 66160, United States. Hauptthemen laut MEDLINE: NK Cell Lectin-Like Receptor Subfamily K, Killer Cells, Natural, Signal Transduction, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: University of Kansas Endowment Foundation, NCI NIH HHS, V Foundation for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Studies support a role for natural killer (NK) cells in cancer control, making these cells attractive for immunotherapy. One method being tested to make effective NK cells is the ex vivo activation with interleukin (IL)-12, IL-15, and IL-18. We demonstrate that this induces NKG2D ligands on NK cells. By engaging NKG2D, this NKG2D ligand expression eliminated the ability of both mouse and human NK cells to control tumor growth in vivo and in vitro, respectively. NKG2D-NKG2D ligand interaction between mouse NK cells reduced NK cell proliferation, CD25 and T-bet expression, and tumor necrosis factor and interferon γ release. NKG2D signaling induced between human NK cells similarly decreased interferon γ but did not affect T-bet or CD25 expression. These data demonstrate that NKG2D signaling can cross-tolerize cytokine signaling and suggest that eliminating this signaling could be beneficial in NK cell adoptive therapy. Further, these results highlight a need to better delineate effects downstream of NKG2D signaling in human, rather than mouse, NK cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NK Cell Lectin-Like Receptor Subfamily KKiller Cells, NaturalSignal TransductionCytokinesAnimalsHumansMiceLigandsMice, Inbred C57BLCell Line, TumorLymphocyte ActivationInterleukin-15

Stichwörter der Autor:innen

NK cellsNKG2Dcross-tolerizationcytokinestumor immunity

Substanzen

NK Cell Lectin-Like Receptor Subfamily KLigandsKlrk1 protein, mouseCytokinesKLRK1 protein, humanInterleukin-15

Autor:innen und Institutionen

  • Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, KS 66160, United States.

ORCID-Profile: Mary A Markiewicz

Förderung

  • University of Kansas Endowment Foundation
  • NCI NIH HHS
  • V Foundation for Cancer Research
  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Cancer Institute Cancer Center

Zitieren

APA

Bedrosian, Z. K., Ruark, E. M., Sharma, N., Silverstein, R. B., Manning, A., Kohlsaat, L., & Markiewicz, M. A. (2025). NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunity. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf030

Vancouver

Bedrosian ZK, Ruark EM, Sharma N, Silverstein RB, Manning A, Kohlsaat L, et al. NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunity. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf030

BibTeX
@article{Bedrosian2025,
  author = {Bedrosian, Zoe K and Ruark, Elizabeth M and Sharma, Neekun and Silverstein, Rachel B and Manning, Allison and Kohlsaat, Lauren and Markiewicz, Mary A},
  title = {NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunity},
  journal = {The Journal of Immunology},
  year = {2025},
  doi = {10.1093/jimmun/vkaf030}
}
Kostenlos starten →